Abstract CT200: Safety and efficacy of HLA-G-targeted CAR T cells (IVS-3001) in patients with advanced HLA-G-positive solid tumors: Clinical trial in progress
Authors
Amir A. Jazaeri (ORCID: https://orcid.org/0000-0003-4335-4151)
Abstract CT200: Safety and efficacy of HLA-G-targeted CAR T cells (IVS-3001) in patients with advanced HLA-G-positive solid tumors: Clinical trial in progress
Amir A. Jazaeri, Aung Naing, Israa Salih, Matthew T. Campbell et al.
Citations
1 citations
Journal
Cancer Research
Topics
CAR-T cell therapy research
Field-Weighted Citation Impact (FWCI)
1.05
article
Abstract CT200: Safety and efficacy of HLA-G-targeted CAR T cells (IVS-3001) in patients with advanced HLA-G-positive solid tumors: Clinical trial in progress
Amir A. Jazaeri, Aung Naing, Israa Salih, Matthew T. Campbell, Jake A. Kushner, David S. Hong, Yago L. Nieto, Serdar A. Gurses, Samer A. Srour, Ying Yuan, Jane Koo, Siqing Fu, Cara Haymaker, Nizar M. Tannir, Funda Meric‐Bernstam, Valérie Doppler, Julie Garibal, Yali Yang, Marie Escande, Melissa Yang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer ResearchVol. 85(8_Supplement_2)
Institutions
The University of Texas MD Anderson Cancer Center (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Abstract CT200: Safety and efficacy of HLA-G-targeted CAR T cells (IVS-3001) in patients with advanced HLA-G-positive solid tumors: Clinical trial in progress — Amir A. Jazaeri, Aung Naing, et al. · Cancer Research (2025) | TGRS Research Map | TGRS